Concepedia

Clarence Hale

CH

45

Publications

3.9K

Citations

30

H-Index

1940

Active since

Affiliations

Amgen (United States)(Current)

Medical Research Council

Lister Institute of Preventive Medicine

University of Oxford

Swedish Orphan Biovitrum (Sweden)

Clarence Hale is an author at Amgen (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryDrug DiscoveryNatural SciencesHealthPhysiologyMetabolic SyndromeMolecular PharmacologyDiabetes

Publications per year

1940–2021

45

Publications

45

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Jing Xu, David J. Lloyd, Clarence Hale et al. · Diabetes · 2008 · 1.1K citations · Full text

Histochemical Demonstration of Acid Polysaccharides in Animal Tissues

Clarence Hale · Nature · 1946 · 380 citations · Full text

Animal Physiology, Biochemistry, Physiology +7

Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys

Yumei Xiong, Kenneth W. Walker, Xiaoshan Min et al. · Science Translational Medicine · 2017 · 226 citations

Immunology, Food Intake, Long-acting Mic-1/gdf15 Molecules +17

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models

Elizabeth A. Killion, Jinghong Wang, Junming Yie et al. · Science Translational Medicine · 2018 · 217 citations · Full text

Glp-1r Agonists, Anti-obesity Effects, Immunology +20

Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance

Clarence Hale, Michelle Chen, Shanaka Stanislaus et al. · Endocrinology · 2011 · 179 citations

Metabolic Disorder, Caloric Restriction, Potential Fgf21 Resistance +25

Rows per page

1–5 of 45